---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "3i5fHeYJNTCJy8QPdQuw3/XjtHBnG/SwK4y3xWZm12EGGZc9rsXyDrsXGERTRlL0QR+mrLwTlJlVgBKnm69BNeDrG3/JqPgsaPvCWEZuaL8krPzH6XEyOcXQy0aOjgiXlv7/Lq6OuLTH5ecbROCYFmhtQsVKVRc89p5T/GtQ9ai7kUawQbJO8dyR7Vul66jk/3pxQNM9MIDKyRmB+LH2CTsKPG7Zb6NKL9e/LDKAV0+oy6EC/gxhGRAJhDkqU1zg3wTrikP7tgqLZ6kg5utGb59jyisspimmabkeWFPolKczJV00x2Ac1V8hJRZxk0agUc/r5J0As9/3/aqv+AGywEKbqfgoyq5imhgG1K71tF0=;8BdSL30QmAvEdeGbf61+KA=="
---

